3,787
Views
23
CrossRef citations to date
0
Altmetric
Review

Current research toward optimizing dosing of first-line antituberculosis treatment

&
Pages 27-38 | Received 18 Sep 2018, Accepted 29 Nov 2018, Published online: 12 Dec 2018

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (1)

Rachel Dwilow, Charles Hui, Fatima Kakkar & Ian Kitai. (2022) Chapter 9: Pediatric tuberculosis. Canadian Journal of Respiratory, Critical Care, and Sleep Medicine 6:sup1, pages 129-148.
Read now

Articles from other publishers (22)

Carola Oelofse, Carene Anne Alene Ndong Sima, Marlo Möller & Caitlin Uren. (2023) Pharmacogenetics as part of recommended precision medicine for tuberculosis treatment in African populations: Could it be a reality?. Clinical and Translational Science 16:7, pages 1101-1112.
Crossref
Belén P Solans, Agathe Béranger, Kendra Radtke, Ali Mohamed, Fuad Mirzayev, Medea Gegia, Nguyen Nhat Linh, Samuel G Schumacher, Payam Nahid & Radojka M Savic. (2023) Effectiveness and Pharmacokinetic Exposures of First-Line Drugs Used to Treat Drug-Susceptible Tuberculosis in Children: A Systematic Review and Meta-Analysis. Clinical Infectious Diseases 76:9, pages 1658-1670fc.
Crossref
Agathe Béranger, Adrie Bekker, Belén P Solans, Mark F Cotton, Mark Mirochnick, Avy Violari, Jiajia Wang, Mae Cababasay, Lubbe Wiesner, Renee Browning, Jack Moye, Edmund V Capparelli & Radojka M Savic. (2022) Influence of NAT2 Genotype and Maturation on Isoniazid Exposure in Low-Birth-Weight and Preterm Infants With or Without Human Immunodeficiency Virus (HIV) Exposure. Clinical Infectious Diseases 75:6, pages 1037-1045.
Crossref
Justin J. Wilkins, Elin M. Svensson, Jacqueline P. Ernest, Radojka M. Savic, Ulrika S.H. Simonsson & Helen McIlleron. (2022) Pharmacometrics in tuberculosis: progress and opportunities. International Journal of Antimicrobial Agents 60:3, pages 106620.
Crossref
Medha Bargaje, Sandeep Bharaswadkar, Sathiyanarayanan Lohidasan & Bijoy Kumar Panda. (2022) Plasma drug concentrations of 4-drug fixed-dose combination regimen and its efficacy for treatment of pulmonary tuberculosis under National Tuberculosis Elimination Programme: A prospective pilot study. Indian Journal of Tuberculosis 69:3, pages 311-319.
Crossref
Stefania Berton, Lu Chen, Yi Chu Liang, Zhongliang Xu, Afrakoma Afriyie-Asante, Nusrah Rajabalee, Weibo Yang & Jim Sun. (2022) A selective PPM1A inhibitor activates autophagy to restrict the survival of Mycobacterium tuberculosis. Cell Chemical Biology 29:7, pages 1126-1139.e12.
Crossref
Chishala Chabala, Anna Turkova, Anneke C Hesseling, Kevin M Zimba, Marieke van der Zalm, Monica Kapasa, Megan Palmer, Maxwell Chirehwa, Lubbe Wiesner, Eric Wobudeya, Aarti Kinikar, Vidya Mave, Syed Hissar, Louise Choo, Kristen LeBeau, Veronica Mulenga, Robb Aarnoutse, Diana Gibb & Helen McIlleron. (2022) Pharmacokinetics of First-Line Drugs in Children With Tuberculosis, Using World Health Organization–Recommended Weight Band Doses and Formulations. Clinical Infectious Diseases 74:10, pages 1767-1775.
Crossref
Helen McIlleron. (2022) Treating children with tuberculosis—Using pharmacometrics to do better. British Journal of Clinical Pharmacology 88:3, pages 894-896.
Crossref
Ronald van Toorn, Stefan-Dan Zaharie, James A. Seddon, Martijn van der Kuip, A. Marceline van Furth, Johan F. Schoeman & Regan S. Solomons. (2021) The use of thalidomide to treat children with tuberculosis meningitis: A review. Tuberculosis 130, pages 102125.
Crossref
V. G. Nesterenko, R. N. Bolgarin, B. A. Rudoy, D. K. Salakhetdinov, Yu. G. Kazaishvili, V. S. Scherbakova, N. A. Nikitina, Yu. V. Medvedev, E. N. Fisher, E. A. Malashenko & I. E. Shohin. (2021) Development of a Gastro-retentive Dosage Form of a New Promising Anti-tuberculosis Drug Macozinone. Drug development & registration 10:3, pages 55-69.
Crossref
Rhastin A D Castro, Sonia Borrell & Sebastien Gagneux. (2021) The within-host evolution of antimicrobial resistance in Mycobacterium tuberculosis . FEMS Microbiology Reviews 45:4.
Crossref
Tom G Jacobs, Elin M Svensson, Victor Musiime, Pablo Rojo, Kelly E Dooley, Helen McIlleron, Rob E Aarnoutse, David M Burger, Anna Turkova, Angela Colbers, Elaine Abrams, Moherndran Archary, Yodit Belew, Brookie Best, David Burger, Jessica Burry, Edmund Capparelli, Deborah Carpenter, Esther Casas, Polly Clayden, Diana Clarke, Tim Cressey, Angela Colbers, Mutsa Dangarembizi, Paolo Denti, Karim Diop, Andrea Ecker, Shaffiq Essajee, Carlo Giaquinto, Diana Gibb, Rohan Hazra, Maria Kim, Marc Lallemant, Janice Lee, Linda Lewis, Shahin Lockman, Mark Mirochnick, Lynne Mofenson, Victor Musiime, Elizabeth Obimbo, Atieno Ojoo, Fernando Pascual, Martina Penazzato, Jorge Pinto, Natella Rakhmanina, Pablo Rojo, Ted Ruel, George Siberry, Nandita Sugandhi, Anna Turkova, Marissa Vicari, Melynda Watkins & Hilary Wolf. (2020) Pharmacokinetics of antiretroviral and tuberculosis drugs in children with HIV/TB co-infection: a systematic review. Journal of Antimicrobial Chemotherapy 75:12, pages 3433-3457.
Crossref
Bijoy Kumar Panda, Medha Bargaje & Sathiyanarayanan L.. (2020) A simple and reliable analytical method for simultaneous quantification of first line antitubercular drugs in human plasma by LCMS/MS. Analytical Methods 12:31, pages 3909-3917.
Crossref
Ana Patricia Huerta-García, Susanna Edith Medellín-Garibay, Arturo Ortiz-Álvarez, Martín Magaña-Aquino, Cristian Jazmín Rodríguez-Pinal, Diana Patricia Portales-Pérez, Silvia Romano-Moreno & Rosa del Carmen Milán-Segovia. (2020) Population pharmacokinetics of isoniazid and dose recommendations in Mexican patients with tuberculosis. International Journal of Clinical Pharmacy 42:4, pages 1217-1226.
Crossref
Annaleise R. Howard-Jones & Ben J. Marais. (2020) Tuberculosis in children. Current Opinion in Pediatrics 32:3, pages 395-404.
Crossref
Lebogang Kenaope, Hannetjie Ferreira, Faheem Seedat, Kennedy Otwombe, Neil A. Martinson & Ebrahim Variava. (2020) Sputum culture and drug sensitivity testing outcome among X-pert Mycobacterium tuberculosis/rifampicin-positive, rifampicin-resistant sputum: A retrospective study — Not all rifampicin resistance is multi-drug resistant. Journal of Global Antimicrobial Resistance 21, pages 434-438.
Crossref
Mariana Millan Fachi, Raquel Oliveira Vilhena, Beatriz Boger, Eric Luiz Domingos, Josiane Marlei Müller Fernandes Santos, Allan Michael Junkert, Alexandre Fátima Cobre, Danilo Raul Ossufo Momade, Francisco Beraldi‐Magalhães, Marcus Vinicius Liz, Marcelo Cordeiro‐Santos & Roberto Pontarolo. (2020) LC–QToF–MS method for quantification of ethambutol, isoniazid, pyrazinamide and rifampicin in human plasma and its application. Biomedical Chromatography 34:5.
Crossref
Jan-Willem C Alffenaar, Tawanda Gumbo, Kelly E Dooley, Charles A Peloquin, Helen Mcilleron, Andre Zagorski, Daniela M Cirillo, Scott K Heysell, Denise Rossato Silva & Giovanni Battista Migliori. (2020) Integrating Pharmacokinetics and Pharmacodynamics in Operational Research to End Tuberculosis. Clinical Infectious Diseases 70:8, pages 1774-1780.
Crossref
Rob C. van Wijk, Rami Ayoun Alsoud, Hans Lennernäs & Ulrika S. H. Simonsson. (2020) Model-Informed Drug Discovery and Development Strategy for the Rapid Development of Anti-Tuberculosis Drug Combinations. Applied Sciences 10:7, pages 2376.
Crossref
Tony T. Tahan, Betina M.A. Gabardo & Andrea M.O. Rossoni. (2020) Tuberculosis in childhood and adolescence: a view from different perspectives. Jornal de Pediatria (Versão em Português) 96, pages 99-110.
Crossref
Tony T. Tahan, Betina M.A. Gabardo & Andrea M.O. Rossoni. (2020) Tuberculosis in childhood and adolescence: a view from different perspectives. Jornal de Pediatria 96, pages 99-110.
Crossref
Christine Sekaggya-Wiltshire, Maxwell Chirehwa, Joseph Musaazi, Amrei von Braun, Allan Buzibye, Daniel Muller, Ursula Gutteck, Ilaria Motta, Andrea Calcagno, Jan S. Fehr, Andrew Kambugu, Barbara Castelnuovo, Mohammed Lamorde & Paolo Denti. (2019) Low Antituberculosis Drug Concentrations in HIV-Tuberculosis-Coinfected Adults with Low Body Weight: Is It Time To Update Dosing Guidelines?. Antimicrobial Agents and Chemotherapy 63:6.
Crossref